---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-391682"
form_type: "8-K"
ticker: "JAGX"
cik: "0001585608"
company_name: "Jaguar Health, Inc."
filed_at: "2026-09-15T17:44:55+00:00"
generated_at: "2026-09-15T17:46:11.856463+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Jaguar Health issues equity to retire debt and acquire Napo Therapeutics minority stake

## Summary
- Issued 557,377 shares to Lincoln Alternative to retire 6% convertible note with $175,016.36 balance on Sept 11, 2026.
- Exchanged 304,473 total shares to Streeterville for 9.2 Series Q preferred shares across 3 agreements (Jul 7, Sep 11, Sep 14, 2026).
- Closed Sep 15 purchase of a shareholder's Napo Therapeutics S.p.A. stake for 535,000 shares plus pre-funded warrant for 2,077,255 shares.
- All issuances under Section 3(a)(9) and 4(a)(2) exemptions; shares free of restrictive legends with Rule 144 holding-period tacking.

## SEC filing metadata
- accession: 0001193125-26-391682
- form_type: 8-K
- ticker: JAGX
- cik: 0001585608
- company_name: Jaguar Health, Inc.
- filed_at: 2026-09-15T17:44:55+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1585608/000119312526391682/0001193125-26-391682-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1585608/000119312526391682/d162139d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-391682
- JSON: https://secwatch.observer/filing/0001193125-26-391682.json
- Plain text: https://secwatch.observer/filing/0001193125-26-391682.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.